The role of NFAT in osteoclast formation

Annals of the New York Academy of Sciences

Volumn 1116, Issue , 2007, Pages 227-237

  Takayanagi, Hiroshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

NFATc1; Osteoclast; Osteoimmunology; RANKL

Indexed keywords

CALCINEURIN; CALCIUM ION; CALMODULIN; COLONY STIMULATING FACTOR 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

BONE DISEASE; BONE MATRIX; CELL DIFFERENTIATION; CONFERENCE PAPER; GENE CONTROL; HUMAN; NONHUMAN; OSTEOCLAST; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 37249090188     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1402.071     Document Type: Conference Paper

References (36)

1. ZAIDI, M. 2007. Skeletal remodeling in health and disease. Nat. Med. 13: 791-801.
2. TEITELBAUM, S.L. & F.P. ROSS. 2003. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4: 638-649.
3. BOYLE, W.J., W.S. SIMONET & D.L. LACEY. 2003. Osteoclast differentiation and activation. Nature 423: 337-342.
4. SUDA, T. et al. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrine Rev. 20: 345-357.
5. TAKAYANAGI, H. 2007. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7: 292-304.
6. ANDERSON, D.M. et al. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390: 175-179.
7. WONG, B.R. et al. 1997. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272: 25190-25194.
8. YASUDA, H. et al. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95: 3597-3602.
9. LACEY, D.L. et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
10. KONG, Y.Y. et al. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315-323.
11. DOUGALL, W.C. et al. 1999. RANK is essential for osteoclast and lymph node development. Genes Dev. 13: 2412-2424.
12. BUCAY, N. et al. 1998. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12: 1260-1268.
13. GOHDA, J. et al. 2005. RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis. EMBO J. 24: 790-799.
14. NAITO, A. et al. 1999. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 4: 353-362.
15. FRANZOSO, G. et al. 1997. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 11: 3482-3496.
16. IOTSOVA, V. et al. 1997. Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nat. Med. 3: 1285-1289.
17. GRIGORIADIS, A.E. et al. 1994. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266: 443-448.
18. TAKAYANAGI, H. et al. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling for terminal differentiation of osteoclasts. Dev. Cell 3: 889-901.
19. ISHIDA, N. et al. 2002. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J. Biol. Chem. 277: 41147-41156.
20. IKEDA, F. et al. 2004. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J. Clin. Invest. 114: 475-484.
21. MATSUO, K. et al. 2004. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J. Biol. Chem. 279: 26475-26480.
22. DE LA POMPA, J.L. et al. 1998. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392: 182-186.
23. RANGER, A.M. et al. 1998. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392: 186-190.
24. ASAGIRI, M. et al. 2005. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202: 1261-1269.
25. WINSLOW, M.M. et al. 2006. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev. Cell 10: 771-782.
26. KIM, N., M. TAKAMI, J. RHO, et al. 2002. A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J. Exp. Med. 195: 201-209.
27. KOGA, T. et al. 2004. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428: 758-763.
28. MOCSAI, A. et al. 2004. The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc. Natl. Acad. Sci. USA 101: 6158-6163.
29. MAO, D., H. EPPLE, B. UTHGENANNT, et al. 2006. PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. J. Clin. Invest. 116: 2869-2879.
30. SATO, K. et al. 2006. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat. Med. 12: 1410-1416.
31. MATSUMOTO, M. et al. 2004. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J. Biol. Chem. 279: 45969-45979.
32. CROTTI, T.N. et al. 2006. NFATc1 regulation of the human β3 integrin promoter in osteoclast differentiation. Gene 372: 92-102.
33. KIM, K. et al. 2005. Nuclear factor of activated T cells c1 induces osteoclastassociated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J. Biol. Chem. 280: 35209-35216.
34. KIM, Y. et al. 2005. Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis. J. Biol. Chem. 280: 32905-32913.
35. YAGI, M. et al. 2005. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 202: 345-351.
36. LEE, S.H. et al. 2006. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat. Med. 12: 1403-1409.